Cluster "Health" WP 2021-2022* - 10 giugno, 2021 Sapienza Università Roma - La Sapienza
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Cluster «Health»
WP 2021-2022*
cluster1@apre.it
Caterina Buonocore
10 giugno, 2021 Sapienza Università Roma * La presentazione recupera ed
elabora materiale della EC sul
programma Horizon Europe. Link
VERSO IL TRAGUARDO… SIAMO QU
Luglio 2018 Aprile 2019 Luglio 2019 Aprile 2020 Novembre 2020 Gennaio 2021 Marzo2021 Maggio 2021
EU Elections New European Commission
26/4 – Voto finale PE
Horizon Europe negotiations - 1st phase Horizon Europe negotiations – 2nd phase Horizon Europe
(Parliament + Council) (Parliament + Council) APPROVED
Commission Proposal Partial Agreement Final Agreement Council approval
(June 2018) Consolidated Text (April 2019) (Dec 2020) (16 Mar 2021)
Strategic Planning + Missions + Partnerships
(Strategic Programme Committee Shadow + others)
Open Consultation Strategic Plan
Specific missions
(June - August 2019) adopted (15 March 2021)
proposed
2021-22 W
Work Programme Preparation
(Thematic Programme Committees Shadow) ADOPTED
Start of WP Preparation ERC WP EIC WP
(Feb 2020) adopted adopted
Più fonti di finanziamento per le politiche sanitarie
Altri programmi dell'UE
forniranno ulteriori
rescEU
investimenti nel settore
della salute, FESR
Digital
complementari a Europe
Horizon Europe. FSE+
EU4Health Horizon
Europe
Guida alla documentazione: dove trovare cosa Legal texts (Framework Programme & Specific Programme): objectives, structure, budget, R&I activities, rules… Strategic Plan 2021-24: strategic orientations for R&I, missions, partnerships… Work Programmes 2021-22: calls, topics… Proposal templates: RIA, IA, CSA, ERC… Model Grant Agreement Reference documents (European Commission): Funding and Tenders portal Tutti i documenti disponibili su Horizon Europe (APRE): https://horizoneurope.apre.it/documenti-di-riferimento/ NEW! Gli Infodays della CE dal 28 giugno all’8 luglio!: https://www.horizon-europe-infodays2021.eu/ https://www.horizon-europe-infodays2021.eu/event/cluster-1-health Brokerage event per il Cluster 1 : 5 luglio, 2021 https://healthbe2021.b2match.io/
HORIZON EUROPE (2021 – 2027) ~ € 95,5 billion Pillar 2: € 53,52 bn Health: € 8,25 bn
SPECIFIC OBJECTIVES Areas of intervention
Cluster Health
Improving and protecting the health of Health throughout the life course
citizens at all ages, by developing
innovative solutions to prevent, diagnose, Non-communicable and rare diseases
CLUSTER 1. Health
monitor, treat and cure diseases; Tools, technologies and digital
mitigating health risks, protecting solutions for health and care, including
populations and promoting good health; personalised medicine
making public health systems more cost- Environmental and social health
effective, equitable and sustainable; and determinants
supporting and enabling patients’ Infectious diseases, including poverty-
participation and self-management. related and neglected disease
Health care systems
6
Cluster Health
IL NUOVO GLOSSARIO NEL QUADRO LOGICO • Salute lungo l'arco della vita
• Malattie non trasmissibili e rare
• Strumenti, tecnologie e soluzioni
digitali per la salute e l'assistenza,
compresa la medicina personalizzata
Base Pillar/Cluster
Aree di • Determinanti ambientali e sociali della
salute
intervento
legale • Malattie infettive, comprese le
malattie correlate alla povertà e
trascurate
• Sistemi sanitari
Piano Priorità
KSO –
Orientamenti
Impatti attesi
politiche EU (impacts)
Strategico strategici
Piano di Destinazioni Topic
Risultati
attesi
lavoro (outcomes)
7
WORK PROGRAMME “HEALTH” 2021-2022
Relazione con il Piano Strategico 2021-2024
▪ 2 Key Strategic Orientations ▪ 4 impact areas (Piano Strategico):
(Piano Strategico): ▪ Good health and high-quality accessible
▪ Promoting an open strategic healthcare
autonomy by leading the ▪ A resilient EU prepared for emerging
development of key digital, threats
enabling and emerging ▪ High quality digital services for all
technologies, sectors and
▪ Competitive and secure data-economy
value chains
▪ Creating a more resilient,
inclusive and democratic
European society
WORK PROGRAMME “HEALTH” 2021-2022 6 Destinations 1. Staying Healthy in a rapid changing society 2. Living and working in a health-promoting environment 3. Tackling diseases and reducing disease burden 4. Ensuring access to innovative, sustainable and high-quality health care 5. Unlocking the full potential of new tools, technologies and digital solutions for a healthy society 6. Maintaining an innovative, sustainable and globally competitive health industry 14/06/2021 9
CLUSTER HEALTH | DESTINATION 1
Staying healthy in a
rapidly changing
society
▪ Affronta le principali sfide sociali come l'obesità, TOPICS 2021:
l'invecchiamento e il cambiamento demografico, ✓ Towards a molecular and neurobiological understanding
la salute mentale, l’empowerment nell’ambito of mental health and mental illness for the benefit of
della digital health literacy, la prevenzione citizens and patients - RIA
personalizzata e l'Intelligenza Artificiale applicata ✓ Healthy Citizens 2.0 - Supporting digital empowerment
alle malattie croniche. and health literacy of citizens - CSA
▪ Progetti di ricerca e innovazione che ✓ A roadmap for personalised prevention - CSA
forniscano nuove evidenze, metodologie e ✓ Mobilising a network of National Contact Points (NCPs)
strumenti per comprendere la transizione for the Health Cluster - CSA
dalla salute alla malattia. Scadenza : 21 Settembre 2021 – SINGLE STAGECLUSTER HEALTH | DESTINATION 1
Staying healthy in a
rapidly changing
society
▪ Affronta le principali sfide sociali come l'obesità, TOPICS 2022:
l'invecchiamento e il cambiamento demografico, ✓ Boosting mental health in Europe in times of change –
la salute mentale, l’empowerment nell’ambito RIA
della digital health literacy, la prevenzione ✓ Trustworthy artificial intelligence (AI) tools to predict the
personalizzata e l'Intelligenza Artificiale applicata risk of chronic non-communicable diseases and/or their
alle malattie croniche. progression – RIA
▪ Progetti di ricerca e innovazione che ✓ Prevention of obesity throughout the life course – RIA
forniscano nuove evidenze, metodologie e
strumenti per comprendere la transizione Scadenza: 1 Febbraio/6 Settembre 2022 – TWO-STAGE
dalla salute alla malattia. ✓ Personalised blueprint of chronic inflammation in health-
to-disease transition – RIA
Scadenza: 21 Aprile 2022 – SINGLE STAGEDESTINATION 1 | HORIZON-HLTH-2021-STAYHLTH-01-02
▪ Towards a molecular and ✓ Deeper understanding of
(epi)genetics, environmental risks
neurobiological understanding and resilience factors
EXPECTED OUTCOMES & SCOPE
of mental health and mental ✓ Biomarkers discovery
illness for the benefit of citizens ✓ Comprehensive clinical trial data on
and patients the effectiveness of different (non-)
pharmacological prevention
strategies
Type of Action Research & Innovation Action (RIA)
Expected EU About EUR 10.00 million
✓ Prediction of treatment response
and risk of relapse
contribution
per project ✓ Multidisciplinary research, incl.
6 PROGETTI
medical sciences, psychological
Budget EUR 60.00 million sciences & social sciences and
Deadline 21 Settembre 2021 – SINGLE STAGE humanitiesCLUSTER HEALTH | DESTINATION 2
Living and working in
a health-promoting
environment*
▪ Comprendere gli impatti dell'inquinamento atmosferico TOPICS 2021:
indoor/outdoor, delle sostanze chimiche, dei campi ✓ Exposure to electromagnetic fields (EMF) and health - RIA
elettromagnetici, dell'urbanizzazione, del cambiamento ✓ Indoor air quality and health – RIA
climatico e di altri cambiamenti ambientali, delle ✓ Health impacts of climate change costs and benefits of
disuguaglianze socioeconomiche e del cambiamento degli action and inaction – RIA
ambienti di lavoro. ✓ European partnership for the assessment of risks from
▪ Rafforzare la capacità di adattamento e la resilienza delle chemicals (PARC) - Programme Co-fund Action
popolazioni e dei sistemi sanitari rispetto ai rischi per la
salute legati ai cambiamenti climatici e ambientali.
Scadenza : 21 Settembre 2021 – SINGLE STAGE
* Forte connessione con European Green DealCLUSTER HEALTH | DESTINATION 2
Living and working in
a health-promoting
environment*
▪ Comprendere gli impatti dell'inquinamento atmosferico TOPICS 2022:
indoor/outdoor, delle sostanze chimiche, dei campi ✓ Methods for assessing health-related costs of
elettromagnetici, dell'urbanizzazione, del cambiamento environmental stressors – RIA
climatico e di altri cambiamenti ambientali, delle
disuguaglianze socioeconomiche e del cambiamento degli
ambienti di lavoro. Scadenza : 21 Aprile 2022 – SINGLE STAGE
▪ Rafforzare la capacità di adattamento e la resilienza delle
popolazioni e dei sistemi sanitari rispetto ai rischi per la
salute legati ai cambiamenti climatici e ambientali.
* Forte connessione con European Green DealDESTINATION 2 | HORIZON-HLTH-2021-ENVHLTH-02-02
▪ Indoor air quality and health ✓ FAIR data on air pollutants
determinants, sources and risk
factors
EXPECTED OUTCOMES & SCOPE
✓ User-friendly solutions to monitor
indoor air quality
✓ Proposals for revised indoor air
quality standards
Type of Action Research & Innovation Action (RIA) ✓ Identification of sources and routes
Expected EU About EUR 8 million
of exposure and dispersion of
chemical and biological indoor air
contribution pollution
per project 5 PROGETTI
✓ Development of scalable
Budget EUR 40.00 million technologies to improve indoor air
Deadline 21 Settembre 2021 – SINGLE STAGE quality and reduce disease burdensCLUSTER HEALTH | DESTINATION 3
Tackling diseases
TOPICS 2021:
and reducing ✓ Improved supportive, palliative, survivorship and end-of-
disease burden* life care of cancer patients - RIA
✓ Building a European innovation platform for the
▪ Si concentra sulle principali sfide sociali come il cancro, le repurposing of medicinal products – RIA
malattie non trasmissibili, le malattie rare, la resistenza ✓ Innovative approaches to enhance poverty-related
antimicrobica, la vaccinazione e la preparazione alle diseases research in sub-Saharan Africa - RIA
epidemie. ✓ Clinical validation of AI solutions for treatment and care –
▪ Sviluppo di nuove misure di prevenzione, terapie e RIA
tecnologie sanitarie innovative. ✓ Personalised medicine and infectious diseases:
understanding the individual host response to viruses
(e.g. SARS-CoV-2) – RIA
✓ A roadmap towards the creation of the European
partnership on One Health antimicrobial resistance (OH
* Complementare a Europe’s Beating Cancer AMR) – CSA
Plan e EU4Health Programme ✓ Building a European partnership for pandemic
preparedness - CSA
Scadenza : 21 Settembre 2021 – SINGLE STAGECLUSTER HEALTH | DESTINATION 3
Tackling diseases
TOPICS 2022:
and reducing ✓ Pre-clinical development of the next generation of
disease burden* immunotherapies for diseases or disorders with unmet
medical needs - RIA
▪ Si concentra sulle principali sfide sociali come il cancro, le ✓ Vaccines 2.0 - developing the next generation of vaccines –
malattie non trasmissibili, le malattie rare, la resistenza RIA
✓ Development of new effective therapies for rare diseases –
antimicrobica, la vaccinazione e la preparazione alle
RIA
epidemie.
▪ Sviluppo di nuove misure di prevenzione, terapie e Scadenza: 1 Febbraio/6 Settembre 2022 – TWO-STAGE
tecnologie sanitarie innovative.
✓ Pandemic preparedness - RIA
✓ Non-communicable diseases risk reduction in adolescence
and youth (Global Alliance for Chronic Diseases - GACD) - RIA
✓ Support for the functioning of the Global Research
Collaboration for Infectious Disease Preparedness (GloPID-R)
* Complementare a Europe’s Beating Cancer
– CSA
Plan e EU4Health Programme ✓ European partnership fostering a European Research Area
(ERA) for health research – Placeholder – Programme Co-fund
Action
Scadenza: 21 Aprile 2022 – SINGLE STAGEDESTINATION 3 | HORIZON-HLTH-2021-DISEASE-04-04
▪ Clinical validation of artificial ✓ Evidence-based clinical decision
support for affordable treatment,
intelligence solutions for including home-based care
EXPECTED OUTCOMES & SCOPE
treatment and care ✓ Clinical development, testing and
validation of AI-driven treatment and
care options
✓ Measure the (cost-)effectiveness of AI-
driven development of therapeutic
Type of Action Research & Innovation Action (RIA) concepts
Expected EU About EUR 6 million ✓ Healthcare professionals better predict
contribution
patients’ response to personalised
treatment
per project 10 PROGETTI
✓ Focus on traceability, transparency and
Budget EUR 60.00 million auditability of AI algorithms in health
Deadline 21 Settembre 2021 – SINGLE STAGECLUSTER HEALTH | DESTINATION 4
Ensuring access to
innovative, sustainable and
high-quality care*
▪ Sviluppo e adozione di soluzioni sicure, convenienti e TOPICS 2021:
incentrate sulle persone, con particolare attenzione alla ✓ Enhancing quality of care and patient safety - RIA
salute della popolazione, alla resilienza dei sistemi sanitari ✓ Data-driven decision-support tools for better health care
e alle politiche sanitarie basate sull'evidenza scientifica. delivery and policy-making with a focus on cancer – RIA
▪ R&I per supportare i sistemi sanitari nella loro ✓ Health care innovation procurement network - CSA
trasformazione per garantire un accesso equo a
Scadenza : 21 Settembre 2021 – SINGLE STAGE
servizi sanitari sostenibili di alta qualità per tutti i
cittadini.
* Forte sinergia con EU4Health ProgrammeCLUSTER HEALTH | DESTINATION 4
Ensuring access to
innovative, sustainable and
high-quality care* TOPICS 2022:
✓ Pre-commercial research and innovation procurement
▪ Sviluppo e adozione di soluzioni sicure, convenienti e (PCP) for building the resilience of health care systems in
incentrate sulle persone, con particolare attenzione alla the context of recovery - PCP
salute della popolazione, alla resilienza dei sistemi sanitari ✓ Public procurement of innovative solutions (PPI) for
e alle politiche sanitarie basate sull'evidenza scientifica. building the resilience of health care systems in the
▪ R&I per supportare i sistemi sanitari nella loro context of recovery – PPI
trasformazione per garantire un accesso equo a ✓ Better financing models for health systems – RIA
servizi sanitari sostenibili di alta qualità per tutti i ✓ European partnership on transforming health and care
cittadini. systems – Programme Co-fund Action
Scadenza : 21 Aprile 2022– SINGLE STAGE
* Forte sinergia con EU4Health ProgrammeDESTINATION 4 | HORIZON-HLTH-2021-CARE-05-01
▪ Enhancing quality of care and ✓ Develop and implement coherent
quality improvement and patient
patient safety safety strategies
EXPECTED OUTCOMES & SCOPE
✓ Harmonisation and
standardisation of health care
processes
✓ Fill knowledge and practice gaps
Type of Action Research & Innovation Action (RIA) in quality of care and patient
Expected EU About EUR 5 million safety
contribution ✓ Innovative approaches for
per project 5 PROGETTI personalised treatment plans
Budget EUR 25.00 million ✓ Empower and involve patients
Deadline 21 Settembre 2021 – SINGLE STAGE and caregiversCLUSTER HEALTH | DESTINATION 5
Unlocking the full potential of
new tools, technologies and
digital solutions for a healthy
society* TOPICS 2021:
▪ Promuovere lo sviluppo di strumenti, tecnologie e ✓ Smart medical devices and their surgical implantation for
soluzioni digitali per trattamenti, farmaci, dispositivi use in resource-constrained settings - IA
medici, tenendo in considerazione sicurezza, efficacia, ✓ Next generation advanced therapies to treat highly
adeguatezza, accessibilità e valore aggiunto. prevalent and high burden diseases with unmet medical
▪ I dati sanitari e gli strumenti analitici innovativi needs – RIA
vengono utilizzati in modo sicuro ed etico. ✓ Innovative tools for use and re-use of health data (in
particular of electronic health records and/or patient
registries) - RIA
* [!] European Health Data Space per promuovere lo Scadenza : 21 Settembre 2021 – SINGLE STAGE
scambio di dati sanitari e la ricerca transfrontaliera.CLUSTER HEALTH | DESTINATION 5
Unlocking the full potential of
new tools, technologies and
digital solutions for a healthy TOPICS 2022:
✓ Optimising effectiveness in patients of existing
society* prescription drugs for major diseases (except cancer)
▪ Promuovere lo sviluppo di strumenti, tecnologie e with the use of biomarkers - RIA
soluzioni digitali per trattamenti, farmaci, dispositivi ✓ New methods for the effective use of real-world data
medici, tenendo in considerazione sicurezza, efficacia, and/or synthetic data in regulatory decision-making
adeguatezza, accessibilità e valore aggiunto. and/or in health technology assessment – RIA
▪ I dati sanitari e gli strumenti analitici innovativi Scadenza : 21 Aprile 2022– SINGLE STAGE
vengono utilizzati in modo sicuro ed etico.
✓ Computational models for new patient stratification
strategies - RIA
* [!] European Health Data Space per promuovere lo Scadenza: 1 Febbraio/6 Settembre 2022 – TWO-STAGE
scambio di dati sanitari e la ricerca transfrontaliera.DESTINATION 4 | HORIZON-HLTH-2021-TOOL-06-02
▪ Next generation advanced ✓ Test new advanced therapies based
on pluripotent stem cells, gene
therapies to treat highly editing or RNA through clinical trials
EXPECTED OUTCOMES & SCOPE
prevalent and high burden meeting the appropriate regulatory
requirements
diseases with unmet medical ✓ Method development for
needs production and differentiation of
pluripotent stem cells
Type of Action Research & Innovation Action (RIA) ✓ Development/validation of
Expected EU About EUR 6 million ✓ Biological assays & methods that
contribution demonstrate efficacy, delivery,
per project specificity and safety of genome editing
10 PROGETTI products in targeted cells and tissues
Budget EUR 60.00 million ✓ novel RNA-based therapies for non-
communicable diseases
Deadline 21 Settembre 2021 – SINGLE STAGECLUSTER HEALTH | DESTINATION 6
Maintaining an innovative,
sustainable and globally
competitive health industry*
▪ Adozione di tecnologie e innovazioni rivoluzionarie TOPICS 2021:
in grado di integrare gli attori della catena del ✓ Green pharmaceuticals - RIA
valore. ✓ Development, procurement and responsible
management of new antimicrobials – CSA
▪ L'industria sanitaria dell'UE è più competitiva,
✓ Promoting a trusted mHealth label in Europe: uptake of
sostenibile e strategicamente autonoma. technical specifications for quality and reliability of health
and wellness apps - CSA
Scadenza : 21 Settembre 2021 – SINGLE STAGECLUSTER HEALTH | DESTINATION 6
Maintaining an innovative,
sustainable and globally
competitive health industry*
▪ Adozione di tecnologie e innovazioni rivoluzionarie TOPICS 2022:
in grado di integrare gli attori della catena del ✓ Enhancing cybersecurity of connected medical devices -
valore. RIA
✓ Scaling up multi-party computation, data anonymisation
▪ L'industria sanitaria dell'UE è più competitiva,
techniques, and synthetic data generation – RIA
sostenibile e strategicamente autonoma. ✓ New pricing and payment models for cost-effective and
affordable health innovations – RIA
✓ Setting up a European Smart Health Innovation Hub –
CSA
✓ Setting up a European Electronic Health Record Exchange
Format (EEHRxF) Ecosystem - CSA
Scadenza : 21 Aprile 2022 – SINGLE STAGEDESTINATION 4 | HORIZON-HLTH-2021-IND-07-03
▪ Promoting a trusted mHealth ✓ European mHealth label allows more
rapid integration of trusted solutions
label in Europe: uptake of ✓
EXPECTED OUTCOMES & SCOPE
Propose activities that bring together
technical specifications for app developers, health and care system
representatives, medical societies,
quality and reliability of health patient organisations, certification
and wellness apps bodies etc.
✓ Set up a structured dialogue on the
Type of Action Research & Innovation Action (RIA) uptake of the Technical Specifications
Expected EU About EUR 2 million ✓ Co-create, develop and implement an
contribution
action plan on the promotion of the
mHealth label in the health and care
per project 1 PROGETTO system
Budget EUR 2 million ✓ Inclusive dissemination strategy
Deadline 21 Settembre 2021 – SINGLE STAGE✓ Centra lo Scope del topic
TIPS & TRICKS ✓ Attenzione ai criteri di eleggibilità
✓ Excellence: novità e chiarezza degli obiettivi
✓ Impact:
✓ Affrontare tutti gli impatti previsti/richiesti in modo
credibile e quantificabile
✓ Affrontare gli impatti di tipo economico e sociale
con termini e numeri appropriati
✓ Prevedere misure per disseminare e sfruttare i
risultati
✓ Implementation: la proposta è chiara, logica, di facile
lettura, credibile e convincente
✓ Consorzio: il partenariato copre tutte le competenze
richieste, ha l’esperienza e l’expertise necessarie.OLTRE IL CLUSTER 1 «Health» Opportunità per il settore Salute nell’ambito degli altri Cluster del Pillar 2
CLUSTER 2. Culture, creativity and
inclusive society
Democrazia e governance
▪ obiettivo di creare sistemi di governance
democratica sostenibili in un mondo post-
pandemico Strengthening European democratic
Trasformazioni sociali ed economiche values, including rule of law and
▪ La dimensione sanitaria gioca inevitabilmente fundamental rights, safeguarding
un ruolo importante nei bandi che affrontano our cultural heritage, and
le condizioni dei migranti e dei rifugiati in
Europa promoting socio-economic
Futuro sostenibile per l’Europa transformations that contribute to
▪ Inclusività del mercato del lavoro in termini di inclusion and growth,
disabilità, salute, età e invecchiamentoCLUSTER 4. Digital, Industry and
Space
Tecnologie produttive
Materiali avanzati
Internet di prossima generazione
Industrie circolari Reinforcing capacities and securing
Spazio, compresa l'osservazione della terra Europe’s sovereignty in key enabling
Tecnologie abilitanti emergenti
Tecnologie digitali fondamentali, comprese le tecnologie
technologies for digitization and
quantistiche production, and in space technology,
Intelligenza artificiale e robotica to build a competitive, digital, low-
Calcolo avanzato e Big Data
Industria a basse emissioni di CO2 e pulita carbon and circular industry; ensure
Tecnologie abilitanti emergenti a sustainable supply of raw
▪ DESTINATION 2 – INCREASED AUTONOMY IN KEY STRATEGIC
materials; and provide the basis for
VALUE CHAINS FOR RESILIENT INDUSTRY > Biomaterials
database for Health Applications advances and innovation in all global
▪ DESTINATION 4 – DIGITAL AND EMERGING TECHNOLOGIES societal challenges.
FOR COMPETITIVENESS AND FIT FOR THE GREEN DEAL >
Quantum sensing technologies for market uptakeCLUSTER 6. Food, bioeconomy, natural resources, agriculture and environment Osservazione ambientale Agricoltura, silvicoltura e zone rurali Protecting, restoring, sustainably Sistemi circolari managing and using natural and Sistemi alimentari biological resources from land and Biodiversità e risorse naturali sea to address food and nutrition Mari, oceani e acque interne security and the transition to a low Sistemi di innovazione biologici nell'UE carbon, resource efficient circular Bioeconomia economy.
CLUSTER 6 – Destination 2 – Fair, healthy and environmentally-
friendly food systems from primary production to consumption
✓ Improved understanding of the
factors influencing dietary
▪ From farming to food systems behaviour of different target groups
EXPECTED OUTCOMES & SCOPE
▪ Expected topics for 2021: > Means to foster behavioural
▪ Vaccines and diagnostics for priority changes
animal diseases ✓ A scientific basis to support policy
▪ Assessment of alternative proteins and makers and Member States for
dietary shift notably in nutritional and dietary advice and communication
allergy terms
▪ Microbes for healthy and sustainable strategies
food and diets ✓ Ultimate objective to empower
▪ [RIA] Transition to healthy and citizens to make informed food
sustainable dietary behaviour choices
▪ One health approach for Food Nutrition
Security and Sustainable Agriculture ✓ Link with topics on prevention of
(FNSSA) obesityCLUSTER 6 – Destination 6 – Resilient, inclusive, healthy and
green rural, coastal and urban communities
✓ Addressing the issue of poorly
planned urban food environments
▪ Focus here on the communities rather that drive citizens, and children in
EXPECTED OUTCOMES & SCOPE
than on the value chain particular, towards unhealthy
packaged food that is high in
▪ Drive community-led innovations with calories, sugar, salt and saturated
through social and behavioural fat, which contributes to obesity
and diet-related illnesses
sciences dimension
✓ Driving people towards health food
▪ Inclusion and governance key choices and transforming urban
food systems to be healthier
▪ Expected topics for 2021: ✓ Governance and multi-actors
▪ [IA] Integrated urban food system engagement including from higher
policies – how cities and towns can education institutions and research
transform food systems for co-benefits centresPILLAR 2 | TIMELINE ALTRI CLUSTER Pubblicazione WP: giugno 2021 Scadenze call: settembre ottobre 2021 Call 2021: single stage Call 2022: single + two-stage
OLTRE IL PILLAR 2 Opportunità per il settore Salute nell’ambito degli altri Pillar
OLTRE IL PILLAR 2 | PILLAR 3
Stimolare innovazioni pionieristiche creatrici di mercato ed
ecosistemi favorevoli all'innovazione
Consiglio Ecosistemi Istituto europeo
europeo per europei per di innovazione e
l'innovazione l'innovazione tecnologia (EIT)
▪ Sostegno alle ▪ Instaurare un ▪ Riunire gli operatori
innovazioni dal legame con gli fondamentali (ricerca,
potenziale operatori istruzione e imprese)
pionieristico e dell'innovazione a attorno a un obiettivo
creatrici di mercato livello regionale e comune per favorire
nazionale l'innovazione
Proposta della Commissione: 10,5 miliardi Proposta della
di EUR, compresi fino a 500 milioni di EUR Commissione:
per gli ecosistemi 3 miliardi di EUR
37OLTRE IL PILLAR 2 | PILLAR 3: EIC
Supporto all'intero ciclo di innovazione, dalla ricerca e sviluppo allo scale up di tecnologie e
imprese innovative (principalmente start-up e PMI) a livello internazionale.
• Pathfinder(ex-FET):early-stage researchof breakthrough technologies by a
multidisciplinaryconsortium
• Transition:developmarket readinessof most potential researchfindings – openonly to Pathfinderor ERC Pathfinder
PoCprojects
• Accelerator(exSMEInstrument): finalizethe technology, commercialisationand scale-upby single
innovativeSMEs
Transition
▪ Prevalentemente BOTTOM UP Open Calls
▪ Tutti gli strumenti
EIC in APRE: contribuiscono anche alle
eic@apre.it priorità tematiche: Health & Accelerator
Biotech, Digital,Energy,Climate
& Environment: ChallengeCallsOPPORTUNITA’ PER IL SETTORE SALUTE IN EIC
PATHFINDER TRANSITION ACCELERATOR
TRL 1-4 4 – 5/6 5/6 - 9
Single applicant
Single Start-ups & SMEs (incl. spin-out),
CHI PUÒ > 3 partner in > 3 Stati Membri Piccoli consorzi (< 5 partner) Individuals (intending to launch an SME)
PARTECIPARE Single applicant (in alcuni casi)
Small midcaps (equity-only)
Solo basati su ERC PoC & Pathfinder
BLENDED FINANCE
< 2.5 €m grant for tech devpt. / valid.
< 2.5 €m
< € 3m 0.5 - 15 €m investment component for scaling up / other
Validate & demonstrate tech in
COSA Achieve proof of principle & validate
application-relevant environment &
activities.
FINANZIA scientific basis of breakthrough tech Grant only/grant first is possible
develop market readiness
Investment only for small mid-caps or as follow up to
grant only
+ 2 Challenge-based topics: + 1 Challenge-based topic: + 1 Challenge-based topics:
▪ Tools to measure and stimulate activity in ▪ Medical Technology and Devices: ▪ Strategic Digital and Health Technologies (AI-driven
brain tissue from Lab to Patient tools for early diagnostics, point-of-care, bioprocessing 4.0,
▪ Emerging Technologies in Cell and Gene healthcare intelligence services, e-health solutions)
therapy
2 cut-off dates:
19 May (open call)
22 September 9 June
27 October (challenge call)
6 OctoberEU MISSIONS
Legate ad uno o più
cluster del Pillar 2
40EU MISSIONS Adaptation to climate
change, including societal Cluster 5, Cluster 2
Legate ad uno o più transformation
cluster del Pillar 2
Healthy
oceans,
Cluster 6 seas, Cluster 1
coastal Mission Cancer
and inland
waters areas
Climate-neutral Soil health
Cluster 5 and food Cluster 6
and smart cities
41MISSIN CANCER | News
Conquering Cancer: Mission Possible 13 recommendations
Targets by 2030: more than 3 million lives saved, living longer and better:
achieve a thorough understanding of cancer, prevent what is preventable,
optimise diagnosis and treatment, support the quality of life of all people
exposed to cancer, and ensure equitable access to the above across Europe.
Aggiornato la pagina delle Mission sul sito della Commissione:
https://ec.europa.eu/info/horizon-europe/missions-horizon-
europe_en
▪ Nomine dei mission managers e dei vice:
https://ec.europa.eu/info/horizon-europe/missions-horizon-europe_en
▪ Schede per la valutazione dei piani d’implementazione, che dovrebbero
essere presentati a giugno: https://ec.europa.eu/info/horizon-
europe/missions-horizon-europe/assessment-criteria_en13 raccomandazioni Comprensione Prevenzione
Diagnosi e
trattamento
Qualità di vita Accesso equo Azioni trasversali
1 Varare UNCAN.eu – un'iniziativa europea per comprendere il cancro
2 Sviluppare un programma di ricerca a livello dell'UE per individuare i punteggi di rischio (poli)genico
3 Sostenere lo sviluppo e l'attuazione di strategie e politiche efficaci per la prevenzione del cancro negli Stati membri e nell'UE
4 Ottimizzare i programmi di screening esistenti e sviluppare approcci innovativi per lo screening e la diagnosi precoce
5 Promuovere e attuare approcci di medicina personalizzata per tutti i pazienti oncologici in Europa
6 Sviluppare un programma di ricerca a livello dell'UE per tecnologie di diagnosi precoce e di trattamento mini invasivo
Sviluppare un sostegno alle politiche e ai programmi di ricerca a livello dell'UE per migliorare la qualità della vita dei pazienti oncologici e dei
7
sopravviventi, dei familiari e dei prestatori di assistenza, nonché di tutte le persone che presentano una maggiore predisposizione al cancro
Creare un centro digitale europeo per i pazienti oncologici in cui questi ultimi e i sopravviventi possano depositare e condividere i loro dati per
8
un'assistenza personalizzata
9 Conseguire l'equità della salute oncologica nell'UE lungo il decorso della malattia
Istituire una rete completa di infrastrutture oncologiche all'interno degli Stati membri dell'UE e tra essi al fine di aumentare la qualità della ricerca e
10
dell'assistenza
11 Tumori infantili e tumori in adolescenti e giovani adulti: curare di più e curare meglio
12 Accelerare l'innovazione e l'attuazione di nuove tecnologie e creare laboratori viventi incentrati sull'oncologia per sconfiggere il cancro
Trasformare la cultura, la comunicazione e lo sviluppo di capacità
13
in ambito oncologicoMISSI0N CANCER | News Europe-wide platform building on current researches & innovations Investing in new models and technologies interrogating the interactions of cancer and their host as a first approach Integration with longitudinal patient data, samples and biomarkers for identification and translation to patient benefits.
EU PARTNERSHIP | UN NUOVO APPROCCIO
Una nuova generazione di partenariati più ambiziosi a sostegno degli obiettivi
politici dell'UE
▪ Architettura semplificata
Caratteristiche ▪ Approccio strutturato e trasparente all’intero
principali ciclo di vita del partenariato
▪ Orientamento strategico
Co-funded
Co-programmed
Institutionalised
Sulla base di un
Basati su protocolli programma Basati su una visione
d'intesa / accordi congiunto concordato a lungo termine e sulla
contrattuali; attuati in dai partner; impegno necessità di un'elevata
modo indipendente dei partner con integrazione;
dai partner e dalla contributi finanziari e partenariati basati su
Commissione via in natura e contributo Art.185 /187 del TFUE
Horizon Europe finanziario da e sul regolamento EIT
Horizon Europe
4
5EU PARTNERSHIP | A COSA SERVONO
▪ Strumento usato per delegare una parte
dell’implementazione del Programma quadro.
✓ Contribuire al raggiungimento delle priorità politiche dell'UE
✓ Allineare priorità settoriali al livello Europeo
RAFFORZARE LO
✓ Superare la frammentazione nel panorama della R&I ed SPAZIO EUROPEA
evitare la duplicazione degli sforzi DELLA RICERCA
✓ Raggiungere una massa critica di investimenti (importante in
HE)
✓ Creare dei network europei (autosufficienti sul lungo
termine)EU PARTNERSHIP | SALUTE
▪ Institutionalised Partnerships:
▪ Innovative Health Initiative (2021) (ex-IMI2)
▪ European Partnership for EU-Africa Global Health (2021) (ex- Draft proposals of the
EDCTP2) candidates for
▪ Co-funded Partnerships: European Partnerships
in Health:
▪ European Partnership for the Assessment of Risks from
Chemicals (PARC) (2021) https://ec.europa.eu/in
▪ European Partnership Fostering an ERA for Health research fo/horizon-
(2022) europe/european-
▪ European Partnership on Transforming Health and Care Systems partnerships-horizon-
(2022) europe/candidates-
▪ European Partnership for Personalised Medicine (2023) european-partnerships-
health_en
▪ European Partnership on Rare Diseases (2024)
▪ European Partnership for One Health/AMR Antimicrobial
Resistance (AMR) (2024/25)Email: cluster1@apre.it
Tel. +39 06 48 93 9993
www.apre.itYou can also read
